Prognostic value of indeterminate IFN-γ release assay results in HIV-1 infection

Journal of Clinical Microbiology

Volumn 50, Issue 8, 2012, Pages 2767-2769

  Aichelburg, Maximilian C ^a   Tittes, Julia ^a   Breitenecker, Florian ^a   Reiberger, Thomas ^b   Kohrgruber, Norbert ^a   Rieger, Armin ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DEATH; ESOPHAGUS CANDIDIASIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTERFERON GAMMA RELEASE ASSAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; T CELL DEPLETION; TUBERCULOSIS; WASTING SYNDROME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV WASTING SYNDROME; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84864411014     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01054-12     Document Type: Article

References (10)

1. Aabye MG, et al. 2009. The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One 4:e4220. doi:10.1371/journal.pone.0004220.
2. Aichelburg MC, et al. 2009. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin. Infect. Dis. 48:954-962.
3. Cellestis. 2003. QuantiFERON-CMI. Package insert. Cellestis, Carnegie, Victoria, Australia.
4. Centers for Disease Control and Prevention. 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm. Rep. 41(RR-17):1-19.
5. Clumeck N, Pozniak A, Raffi F. 2008. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults. HIV Med. 9:65-71. (Pubitemid 351228129)
6. Kobashi Y, et al. 2009. Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice. Eur. Respir. J. 33:812-815.
7. Luetkemeyer AF, et al. 2007. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am. J. Respir. Crit. Care Med. 175:737-742. (Pubitemid 46536491)
8. Mori T, et al. 2004. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am. J. Respir. Crit. Care Med. 170:59-64. (Pubitemid 38997752)
9. Rangaka MX, et al. 2012. Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect. Dis. 12:45-55.
10. Richeldi L. 2006. An update on the diagnosis of tuberculosis infection. Am. J. Respir. Crit. Care Med. 174:736-742. (Pubitemid 44511654)